MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0142600
Nacc Pharmaceutical Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹64.14 Lakh
▼ 15% YoY
Net profit · FY 2025
₹1.01 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹4.84 Lakh
EBITDA margin 7.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
6
Provident fund records
Directors on board
2
As per MCA filings
About Nacc Pharmaceutical Private Limited
Data last updated:
Nacc Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24110KA2019PTC130795. Its GSTIN is 29AAGCN8027M1ZV (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkataramanappa Adinarayana Sravan Kumar and Chowdappa Geetha.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No.5 Spandana 1st Flr No.4 1st Main Rd Virupakashapura Kodgehalli Vidyaranyapur, Bangalore, Karnataka, India – 560097.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.14 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹1.01 Lakh (net margin 1.6%) and EBITDA of ₹4.84 Lakh (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: NACC Pharmaceutical.
Nacc Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0142600). For more details, the company can be reached via its website naccpharmaceutical.com.
Company Details of Nacc Pharmaceutical Private Limited
CIN U24110KA2019PTC130795
Registration Number 130795
Incorporation Date 19 December 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0142600
Recognitions & Rankings of Nacc Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo.5 Spandana 1st Flr No.4 1st Main Rd Virupakashapura Kodgehalli Vidyaranyapur, Bangalore, Karnataka, India – 560097
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Nacc Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical operates one associated brand: NACC Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services in healthcare, focusing on innovation and therapeutic solutions in India. | naccpharmaceutical.com |
Business Activity of Nacc Pharmaceutical Private Limited
The main business activity of Nacc Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nacc Pharmaceutical Private Limited FY 2023 filings available
Nacc Pharmaceutical Private Limited reported revenue of ₹64.14 Lakh (down 15% YoY) for FY 2025.
Revenue · FY 2025
₹64.14 Lakh ▼ 15%
Net profit · FY 2025
₹1.01 Lakh margin 1.6%
EBITDA · FY 2025
₹4.84 Lakh margin 7.5%
Compounded Annual Growth Rate (CAGR) of Nacc Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 7%
5 years · compounded
▲ 26%
Revenue fell 15% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nacc Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.84 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.01 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nacc Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nacc Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkataramanappa Adinarayana Sravan Kumar | Director | 19 Dec 2019 | 6 Years 10 Months | Current |
| Chowdappa Geetha | Additional Director | 11 Jan 2025 | 1 Years 9 Months | Current |
Peer Comparison of Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Consumer Services industry (Consulting Services, Professional Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ubuntoo India Private Limited | ₹64.19 Lakh (FY 2025) | •••• | •••• | 107.0% | •••• | Gurgaon, Haryana, India |
| Marigold Commercial Co Private Limited | ₹64.18 Lakh (FY 2015) | •••• | •••• | 417.0% | •••• | Kolkata, West Bengal, India |
| Kaladi Consulting Services Private Limited | ₹64.17 Lakh (FY 2024) | •••• | •••• | -83.0% | •••• | Chennai, Tamil Nadu, India |
| Unicorn Insights Private Limited | ₹64.17 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Sparktax and Consulting Services Private Limited | ₹64.16 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Hyderabad, Telangana, India |
| Nacc Pharmaceutical Private Limited this company | ₹64.14 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Bangalore, Karnataka, India |
| Hi-Win Projects and Infrastructure Private Limited | ₹64.14 Lakh (FY 2025) | •••• | •••• | 108.0% | •••• | Kottayam, Kerala, India |
| Criticure Laboratory Private Limited | ₹64.1 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Lucknow, Uttar Pradesh, India |
| Pamela Advisory Pvt. Ltd. | ₹64.1 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Kolkata, West Bengal, India |
| Vicino International Technologies Private Limited | ₹64.09 Lakh (FY 2025) | •••• | •••• | 55.0% | •••• | Mumbai, Maharashtra, India |
| Planera Enterprises Private Limited | ₹64.07 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Nacc Pharmaceutical by revenue in the Consumer Services industry (Consulting Services, Professional Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical Private Limited is audited by BHASKAR REDDY & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHASKAR REDDY & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nacc Pharmaceutical Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical Private Limited has a workforce of 6 employees as of Apr 06, 2024.
Employee count
6
Active EPFO establishments
1
Employee growth
-14.29%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Chowdappa Geetha was appointed as Additional Director on 11 Jan 2025.
Appointed
Chowdappa Geetha was appointed as Additional Director.
Ceased
Kummari Subbaiah ceased to be Director.
AGM
Nacc Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Nacc Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Ceased
Nagaraja Shetty Vageesha ceased to be Director.
Appointed
Kummari Subbaiah was appointed as Director.
Appointed
Nagaraja Shetty Vageesha was appointed as Director.
Appointed
Venkataramanappa Adinarayana Sravan Kumar was appointed as Director.
Incorporation
19 Dec 2019
Nacc Pharmaceutical Private Limited was registered on 19 Dec 2019 with Roc Bangalore & aged 6 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Nacc Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nacc Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nacc Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCN8027M1ZV | Karnataka | Active | 30 Jan 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nacc Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 2019 (7+ years old) and is registered under CIN U24110KA2019PTC130795.
Nacc Pharmaceutical reported revenue of ₹64.14 Lakh for FY 2025 (down 15% YoY).
Nacc Pharmaceutical has 2 current directors:
- Venkataramanappa Adinarayana Sravan Kumar - Director
- Chowdappa Geetha - Additional Director
Nacc Pharmaceutical reported a net profit of ₹1.01 Lakh (net margin 1.6%) and EBITDA of ₹4.84 Lakh (EBITDA margin 7.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nacc Pharmaceutical is 7% over three years. In the latest year (FY 2025) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nacc Pharmaceutical is 29AAGCN8027M1ZV, registered in Karnataka.
The CIN (Corporate Identification Number) of Nacc Pharmaceutical is U24110KA2019PTC130795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nacc Pharmaceutical was incorporated on 19 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Nacc Pharmaceutical by revenue are Ubuntoo India Private Limited, Marigold Commercial Co Private Limited, Kaladi Consulting Services Private Limited, Unicorn Insights Private Limited, Sparktax and Consulting Services Private Limited and 5 more, all in the Consumer Services industry (Consulting Services, Professional Services).
Chowdappa Geetha was appointed as Additional Director on 11 Jan 2025. Kummari Subbaiah ceased to be Director on 11 Jan 2025. Nagaraja Shetty Vageesha ceased to be Director on 10 Mar 2022. Nacc Pharmaceutical has 6 board changes on record in total.
Yes, Nacc Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0142600).